NCT01970527: A reported trial by University of Washington
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01970527 |
|---|---|
| Title | RADVAX: A Stratified Phase II Dose Escalation Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Metastatic Melanoma |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 31, 2014 |
| Completion date | Nov. 3, 2018 |
| Required reporting date | Nov. 3, 2019, midnight |
| Actual reporting date | Nov. 1, 2019 |
| Date last checked at ClinicalTrials.gov | Aug. 26, 2025 |
| Days late | None |